SCHEMBL2903191

SCHEMBL2903191

COc1ccc(CNc2cc(F)c3ncc(C(=O)O)n3n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VNN1 O95497 3/20 0.47
KDM4E B2RXH2 2/20 0.47
ASPH Q12797 2/20 0.47
KDM8 Q8N371 2/20 0.47
RIOX2 Q8IUF8 1/20 0.47
FYN P06241 4/20 0.44
PIM1 P11309 1/20 0.44
HDAC1 Q13547 3/20 0.43
ADORA3 P0DMS8 1/20 0.42
ADORA2A P29274 1/20 0.42
ADORA1 P30542 1/20 0.42
EGFR P00533 1/20 0.41
JAK3 P52333 1/20 0.41
BTK Q06187 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC8 Q9BY41 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1202103 0.88 KDM4E (0.47) VNN1KDM4EASPHKDM8RIOX2
SCHEMBL1203679 0.86 SCD (0.43) VNN1FYNPIM1HDAC1HDAC3
SCHEMBL1203600 0.81 FYN (0.59) VNN1KDM4EASPHKDM8RIOX2
SCHEMBL1202665 0.78 GAA (0.52) VNN1KDM4EASPHKDM8RIOX2
SCHEMBL1202002 0.74 PPARA (0.52) HDAC1NPC1RAB9AKMT2APPARA
SCHEMBL2903393 0.74 KDM4E (0.47) VNN1KDM4EASPHKDM8RIOX2
SCHEMBL2905141 0.72 FYN (0.52) FYN
SCHEMBL1202658 0.70 PPARA (0.43) FYNHDAC1NPC1RAB9AKMT2A
SCHEMBL1202088 0.70 FYN (0.63) KDM4EFYNPIM1
SCHEMBL24263413 0.70 TYK2 (0.41) PPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2217601-A1 IMIDAZOPYRIDAZINES FOR USE AS PROTEIN KINASE INHIBITORS Centro Nacional de Investigaciones Oncológicas (CNIO) (ES) 2010-08-18 EP disclosed
WO-2009060197-A1 IMIDAZOPYRIDAZINES FOR USE AS PROTEIN KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS (CNIO) (ES) 2009-05-14 WO disclosed